A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Recruiting · NCT06883305 · Interventional (participants receive a specific treatment) · Lead sponsor: AstraZeneca
View the official record on ClinicalTrials.gov →Interventions studied
PlaceboTezepelumab
What this trial is about
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Who can take part
Age range
40 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- ≥40 to ≤80 years old
- COPD diagnosis ≥1 year,
- Post-BD FEV1 ≥ 20% and ≤ 70% PN, FEV1/FVC \<0.70 at screening
- Triple (ICS+LABA+LAMA) or dual inhaled COPD therapy, if triple therapy is considered not appropriate, ≥3 consecutive months prior to V1
- ≥2 moderate or ≥1 severe COPD exacerbations in the prior year; At least 1 of 2 moderate exacerbations must require the use of systemic corticosteroids. At least one of the previous exacerbations should be confirmed to have occurred while the participant was on triple or dual inhaled maintenance therapy
- EOS ≥ 150 cells/μL during screening
- CAT ≥15 at screening
- Former or current smokers ≥10 pack-years
Exclusion criteria
- Clin. important pulmonary disease or radiological findings suggestive of a respiratory disease other than COPD
- Asthma, incl. pediatric, or ACOS
- Any unstable disorder that can impact participants safety or study outcomes
- Tuberculosis requiring treatment within 12 months prior V2
- Malignancies current or past
- Concomitant therapies:
- Macrolides (less than 6 months)
- Systemic immuno-suppressive, -modulating medications
- LTOT \>4.0 L/min or O2 saturation \<89% despite LTOT
Where it is running
60 locations listed across 29 US states.
- Research Site - Foley, Alabama, United States
- Research Site - Mobile, Alabama, United States
- Research Site - Sheffield, Alabama, United States
- Research Site - Phoenix, Arizona, United States
- Research Site - Phoenix, Arizona, United States
- Research Site - Tucson, Arizona, United States
- Research Site - Garden Grove, California, United States
- Research Site - Newport Beach, California, United States
- Research Site - Torrance, California, United States
- Research Site - Clearwater, Florida, United States
- Research Site - Cutler Bay, Florida, United States
- Research Site - Cutler Bay, Florida, United States
- Research Site - DeBary, Florida, United States
- Research Site - Gainesville, Florida, United States
- Research Site - Homestead, Florida, United States
- Research Site - Miami, Florida, United States
- Research Site - Miami, Florida, United States
- Research Site - Miami, Florida, United States
- Research Site - Orlando, Florida, United States
- Research Site - Tampa, Florida, United States
- Research Site - Tampa, Florida, United States
- Research Site - Atlanta, Georgia, United States
- Research Site - Lithonia, Georgia, United States
- Research Site - Rincon, Georgia, United States
- Research Site - Meridian, Idaho, United States
- Research Site - Chicago, Illinois, United States
- Research Site - Palos Hills, Illinois, United States
- Research Site - Winfield, Illinois, United States
- Research Site - Munster, Indiana, United States
- Research Site - Baltimore, Maryland, United States
- Research Site - Columbia, Maryland, United States
- Research Site - North Dartmouth, Massachusetts, United States
- Research Site - Farmington Hills, Michigan, United States
- Research Site - Saint Cloud, Minnesota, United States
- Research Site - St Louis, Missouri, United States
- Research Site - St Louis, Missouri, United States
- Research Site - Missoula, Montana, United States
- Research Site - Papillion, Nebraska, United States
- Research Site - Las Vegas, Nevada, United States
- Research Site - Millville, New Jersey, United States
- Research Site - Sewell, New Jersey, United States
- Research Site - Toms River, New Jersey, United States
- Research Site - Albuquerque, New Mexico, United States
- Research Site - Buffalo, New York, United States
- Research Site - Buffalo, New York, United States
- Research Site - Cortland, New York, United States
- Research Site - Horseheads, New York, United States
- Research Site - Massapequa, New York, United States
- Research Site - The Bronx, New York, United States
- Research Site - High Point, North Carolina, United States
- Research Site - Kings Mountain, North Carolina, United States
- Research Site - New Bern, North Carolina, United States
- Research Site - Wilmington, North Carolina, United States
- Research Site - Winston-Salem, North Carolina, United States
- Research Site - Columbus, Ohio, United States
- Research Site - Oklahoma City, Oklahoma, United States
- Research Site - DuBois, Pennsylvania, United States
- Research Site - Philadelphia, Pennsylvania, United States
- Research Site - Rock Hill, South Carolina, United States
- Research Site - Franklin, Tennessee, United States
Showing 60 of 305 listed sites. See the official record for the complete list.
Read the full protocol, contacts and eligibility on ClinicalTrials.gov →